Gemcitabine in Treating Patients With Advanced Colorectal Cancer
Status:
Completed
Trial end date:
2001-02-27
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die.
PURPOSE: Phase II trial to study the effectiveness of gemcitabine in treating patients who
have advanced colorectal cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Wake Forest Baptist Health Wake Forest University Health Sciences